Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Sep 2026
From liver disease to malignancy, characteristic skin findings can prompt a broader evaluation and help physicians consider systemic conditions during routine examinations.
Read Full NewsPhase 2a trial results showed 800 mg vutiglabridin significantly improved motor symptom scores compared with placebo in early-stage Parkinson's disease.
Carlos Cruchaga, PhD, director of the NeuroGenomics and Informatics Center at Washington University, discusses emerging blood-based biomarkers for monitoring biological and cognitive responses to lecanemab treatment in Alzheimer disease.
Christen Kutz, PhD, PA-C, discusses a retrospective survey of neurology providers examining why patients with generalized myasthenia gravis are transitioning to nipocalimab and what real-world outcomes data suggest about its role in the treatment landscape.
Mitzi Joi Williams, MD, is joined by Jakai McEwen, DO, and Charnetta Colton-Poole, MD, to discuss the challenges of communication between patients and their health care teams, including navigating medical language, promoting shared decision-making, and advocating for clear, patient-centered care.
An MDS 2026 plenary speaker discusses the evolving role of infusion therapies, deep brain stimulation, and focused ultrasound in Parkinson disease, including when to consider device-aided therapies and how treatment selection can be individualized.
A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.
Lozach outlines how the Corticosteroid Stewardship Alliance plans to bring clinician data and adverse event costs to payers and lawmakers.
1.
Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients
2.
A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.
3.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
4.
EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues
5.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
1.
Myeloproliferative Disorders: Causes, Symptoms and Treatment Options
2.
Risk Assessment of Long-Term Functional Vulnerability After Completion of Cancer Therapy
3.
Glycopyrrolate: The Secret Weapon for Excessive Sweating
4.
Progressive Techniques in Oncology in Daily Practice
5.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
Understanding the Importance of Early Cancer Detection
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge